Correction to "Supramolecular Chemotherapy: Carboxylated Pillar[6]arene for Decreasing Cytotoxicity of Oxaliplatin to Normal Cells and Improving Its Anticancer Bioactivity Against Colorectal Cancer".

Qi Hao,Yueyue Chen,Zehuan Huang,Jiang-Fei Xu,Zhiwei Sun,Xi Zhang

DOI: https://doi.org/10.1021/acsami.8b11812

IF: 9.5

2018-01-01

ACS Applied Materials & Interfaces

Abstract:We have successfully demonstrated that host-guest complex of carboxylated pillar[6]arene with oxaliplatin exhibits low cytotoxicity toward normal cells and displays higher anticancer bioactivity against colorectal cancer cells than oxaliplatin itself. Owing to higher binding affinity of carboxylated pillar[6]arene with spermine than that of with oxaliplatin, the oxaliplatin can be thoroughly released from its host-guest complex by the competitive replacement with spermine. This supramolecular chemotherapy works well both in vitro and in vivo for spermine-overexpressed cancers, such as colorectal cancer. Compared to oxaliplatin itself, anticancer bioactivity of this host-guest complex is further improved by about 20%. Such an improvement results from combined effect of controlled release of oxaliplatin from the host-guest complex and consumption of spermine by carboxylated pillar[6]arene. It is anticipated that this supramolecular strategy may be extended to other clinical anticancer drugs for decreasing their severe side effects and improving their anticancer bioactivity, thus enriching realm of supramolecular chemotherapy.